Welcome to LookChem.com Sign In|Join Free
  • or
HENAN SUNLAKE ENTERPRISE CORPORATIONRivaroxaban Supplier//file1.lookchem.com/cas/reactions/2021/05/26/10206739.png
qq

Communicate with Supplier:

Ms. summer
Ms. summer: What can I do for you?

Rivaroxaban Supplier CAS NO.366789-02-8

Min.Order Quantity:
100 Gram
Purity:
99%
Port:
Shanghai Port
Payment Terms:
L/C,D/A,D/P,T/T,MoneyGram,Other

Add to Inquiry Cart

Product Details

Keywords

  • Rivaroxaban
  • 366789-02-8 supplier
  • 366789-02-8 price

Quick Details

  • ProName: Rivaroxaban Supplier
  • CasNo: 366789-02-8
  • Molecular Formula: C16H15F6N5O
  • Appearance: White Solid
  • Application: pharmaceutical uses
  • DeliveryTime: 7-10 working days
  • PackAge: Fluoride barrel
  • Port: Shanghai Port
  • ProductionCapacity: 100 Kilogram/Week
  • Purity: 99%
  • Storage: Protected from light, stored hermetica...
  • Transportation: By air or courier or sea
  • LimitNum: 100 Gram
  • Molecular Weight: 435.88

Superiority

henan sunlake enterprise corporation

our company advantages:

1、the highest quality with the competitive price.

2、professional human services.

3、the fastest and safest delivery service.

4、the faster and safest delivery service.

5、the high purity products.

6、we have a sufficient supply of stock.

7、a variety of payments, such as l/c, tt, , moneygram or other payments.

company information

henan sunlake enterprise corporation is located in henan province , the central plain of china , which enjoys favorable geogeaphical position and convenient transportion. the com[any was established in june. 1998, until now having more than 18 years experience in manufacturing & exporting chemical raw material .

sunlake is a professional manufacturer engaged in producing and selling chemicals,including organic & inorganic chemicals , pigments & dyestuffs , water treatment chemicals , food & feed additives and others. these products have been being well exported to europe, southeast asia, the middle east ,africa, south america and some other countries and areas.

we sincerely welcome foreign friends to visit our plant for cooperation. with the idea of "quality first,credit priority, excellent service", we are highly acknowledged by customers for good quality and competitive price. more importantly , the company has a strong r & d team, who are professional engineers and scholars with ph. d. .so we are confident to serve you better with our high - quality products and professional team. we are taking great efforts to provide our customers with demanded goods and professional services, and continuously improve our core ability of competition and get the momentum for sustainable development, and finally make us being a reliable and professional supplier in international market.

we welcome any serious inquiries from all customers of the world, and sincerely hope to cooperate with you for a brilliant future!

Details

rivaroxaban basic information

antithrombotic drugs application
product name: rivaroxaban
synonyms: 5-chloro-n-[[(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide;bay 59-7939;rivaroxaban;5-chloro-n-(((5s)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide;2-thiophenecarboxamide, 5-chloro-n-[[(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl];xarelto;(s)-5-chloro-n-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide;rivaroxaban (bay59-7939)
cas: 366789-02-8
mf: c19h18cln3o5s
mw: 435.88
einecs:
product categories: chiral reagents;heterocycles;intermediates & fine chemicals;pharmaceuticals;sulfur & selenium compounds;api;inhibitor;rivaroxaban;pharmaceutical raw materials;inhibitors
mol file: 366789-02-8.mol
rivaroxaban structure
rivaroxaban chemical properties
mp 228-229°c
storage temp. refrigerator
safety information
msds information
rivaroxaban usage and synthesis
antithrombotic drugs rivaroxaban and dabigatran etexilate are currently the most promising antithrombotic drugs, and compared to traditional antithrombotic drugs heparin, essential difference is that it does not require participation of antithrombin ⅲ, directly antagonizes the free and bound xa factor. and heparin needs to have antithrombin ⅲ and can play a role, and is invalid to the prothrombin complex of xa factor. two new oral anticoagulants are praised as as a major step forward of anticoagulant therapy and potentially fatal thrombosis prevention in the medical field, will become a new milestone in the development of cardiovascular drugs.
rivaroxaban was associated research and development success by the german bayer and usa johnson & johnson. in october 2008, get approved for listing in canada and the eu, trade name is xarelto. rivaroxaban is the world's first oral direct xa factor inhibitor, can be high selectively, competitively inhibit free and bound xa factor and activity of prothrombin, in a dose - dependent manner prolonged activated partial thromboplastin time board (pt) and prothrombin time (aptt), thus prolonging the clotting time, reducing thrombin formation. having characteristics of high bioavailability, a wide spectrum of disease treatment, dose effect relationship is stable, convenient oral administration, low bleeding risk.
rivaroxaban also is drug for prevention and treatment of venous thrombosis. clinically for the prevention of forming patients with deep vein thrombosis (dvt) and pulmonary embolism (pe) after hip joint and knee replacement surgery. it can also be used to prevent stroke and non-cns systemic embolism in patients with non-valvular atrial fibrillation, reduce the risk of recurrent coronary syndrome, and so on.
dabigatran is a new antithrombotic drugs with a variety of characteristics developed by a german company boehringer ingelheim. in april 2008, first listed in germany and the uk, trade name was pradaxa. this is listed first oral anticoagulant drug following warfarin in the past 50 years, is another milestone in the field of anticoagulant therapy and potentially fatal thrombosis prevention.
dabigatran is a new synthetic direct thrombin inhibitor, is a prodrug for oral administration, belongs to the thrombin inhibitors of non-peptides. after oral gastrointestinal absorption, it is converted to have a direct anticoagulant activity of dabigatran etexilate in vivo. drug binds to the fibrin-specific binding sites of thrombin, preventing fibrinogen from cleaving into fibrin, thereby blocking the final step of the coagulation cascade network and thrombosis.
the above information is edited by the chemicalbook of liu yujie.
application for elective hip joint or knee replacement surgery in adult patients to prevent venous thrombosis (vte).
chemical properties white solid
usage anti-coagulant, factor x inhibitor
usage a novel antithrombotic agent. a highly potent and selective, direct fxa inhibitor

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

Related Products

Related Keywords

Inquiry Cart 0